Jefferies Group LLC Intra Cellular Therapies, Inc. Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

A detailed history of Jefferies Group LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Jefferies Group LLC holds 6,365 shares of ITCI stock, worth $839,352. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,365

Holding current value

$839,352

% of portfolio

0.0%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Sep 21, 2023	SELL	$42.7 - $59.99 $241,169 - $338,823	-5,648 Reduced 47.02%	6,365 $296,000
Q3 2022 Nov 14, 2022	BUY	$42.7 - $59.99 $512,955 - $720,659	12,013 New	12,013 $308,000
Q1 2020 May 15, 2020	SELL	$12.31 - $33.12 $944,780 - $2.54 Million	-76,749 Reduced 93.31%	5,499 $85,000
Q4 2019 Feb 13, 2020	SELL	$7.26 - $38.49 $276,976 - $1.47 Million	-38,151 Reduced 31.69%	82,248 $2.82 Million
Q3 2019 Nov 13, 2019	BUY	$7.47 - $14.03 $847,000 - $1.59 Million	113,387 Added 1617.04%	120,399 $899,000
Q2 2019 Aug 14, 2019	BUY	$10.65 - $14.29 $74,677 - $100,201	7,012 New	7,012 $91,000
Q4 2017 Feb 14, 2018	SELL	$14.27 - $16.79 $1.33 Million - $1.56 Million	-93,092 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$10.77 - $22.1 $1 Million - $2.06 Million	93,092	93,092 $1.47 Million

Others Institutions Holding ITCI

# of Institutions

Shares Held

12.2M

Call Options Held

600

Put Options Held

Black Rock Inc. New York, NY

6.32M
Shares

$834 Million
0.01% of portfolio
Pictet Asset Management Sa Geneva 73, V8

1.67M
Shares

$220 Million
0.13% of portfolio
Jpmorgan Chase & CO New York, NY

760K
Shares

$100 Million
0.01% of portfolio
Eagle Asset Management Inc St Petersburg, FL

625K
Shares

$82.4 Million
0.27% of portfolio
Nuveen Asset Management, LLC Chicago, IL

519K
Shares

$68.5 Million
0.01% of portfolio

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $12.4B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account